Influence of levothyroxine in augmentation therapy for bipolar depression on central serotonergic function

Pharmacopsychiatry

Volumn 47, Issue 4-5, 2014, Pages 180-183

  Uhl, I ^a   Bez, J A ^b,c   Stamm, T ^c   Pilhatsch, M ^d   Assion, H J ^a   Norra, C ^a   Lewitzka, U ^d   Schlagenhauf, F ^c   Bauer, M ^a,d   Juckel, G ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

augmentation; bipolar depression; levothyroxine; loudness dependence of auditory evoked potentials; serotonin

Indexed keywords

AMFEBUTAMONE; AMISULPRIDE; AMITRIPTYLINE; CITALOPRAM; LAMOTRIGINE; LEVOTHYROXINE; LITHIUM; MIRTAZAPINE; OLANZAPINE; PAROXETINE; PREGABALIN; SEROTONIN; SERTRALINE; TRANYLCYPROMINE; VALPROIC ACID; VENLAFAXINE; ANTIDEPRESSANT AGENT; THYROXINE;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BRAIN ELECTROPHYSIOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EVOKED AUDITORY RESPONSE; FEMALE; HAMILTON SCALE; HUMAN; LOUDNESS DEPENDENCE OF AUDITORY EVOKED POTENTIAL; MALE; MONOTHERAPY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; NEUROTRANSMISSION; PRIORITY JOURNAL; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC SYSTEM; TREATMENT OUTCOME; TREATMENT RESPONSE; YOUNG MANIA RATING SCALE; AGED; DRUG COMBINATION; DRUG EFFECTS; HEARING; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; LOUDNESS PERCEPTION; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN; THYROXINE;

EID: 84904857659     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0034-1383654     Document Type: Article

References (27)

1. Bauer M., Ritter P., Grunze H. et al. Treatment options for acute depression in bipolar disorder. Bipolar Disord: 2012; 14 37 50
2. Bauer M., Whybrow P. C. Thyroid hormone, neural tissue and mood modulation. World J Biol Psychiatr: 2001; 2 57 67
3. Bauer M., Whybrow P. C. Thyroid hormone, brain and behavior. In Pfaff D. W., Arnold A. P., Etgen A. M., Fahrbach S. E., Rubin R. T. (eds.) Hormones, Brain and Behavior. San Diego Academic Press: 2002; 239 264
4. Bauer M., Hellweg R., Gräf K. J. et al. Treatment of refractory depression with high-dose thyroxine. Neuropsychopharmacology: 1998; 18 444 455 (Pubitemid 28202352)
5. Bauer M., London E. D., Rasgon N. et al. Supraphysiological doses of levothyroxine regional cerebral alter metabolism and improve mood in bipolar depression. Mol Psychiatry: 2005; 10 456 469 (Pubitemid 40646434)
6. Henley W. N., Koehnle T. J. Thyroid hormones and the treatment of depression: An examination of basic hormonal actions in the mature mammalian brain. Synapse: 1997; 27 36 44 (Pubitemid 27327600)
7. Whybrow P. C., Prange A. J. Jr. A hypothesis of thyroid-catecholamine- receptor interaction. Arch Gen Psychiatry: 1981; 38 106 113
8. Bauer M., Heinz A., Whybrow P. C. Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol Psychiatry: 2002; 7 140 156 (Pubitemid 34177782)
9. Hegerl U., Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry: 1993; 33 173 187 (Pubitemid 23089966)
10. Juckel G., Molnar M., Hegerl U. et al. Auditory-evoked potentials as indicator of brain serotonergic activity - first evidence in behaving cats. Biol Psychiatry: 1997; 41 1181 1195 (Pubitemid 27237179)
11. Juckel G., Hegerl U., Molnar M. et al. Auditory evoked potentials reflect serotonergic neuronal activity - a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology: 1999; 21 710 716
12. Juckel G., Gallinat J., Riedel M. et al. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res: 2003; 64 115 124 (Pubitemid 37412333)
13. Juckel G., Mavrogiorgou P., Bredemeier S. et al. Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders - a retrospective study. Pharmacopsychiatry: 2004; 37 46 51 (Pubitemid 38651016)
14. Pogarell O., Tatsch K., Juckel G. et al. Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder. Neuropsychopharmacology: 2004; 29 1910 1917 (Pubitemid 39336802)
15. Stamm T., Lewitzka L., Sauer C. et al. Supraphysiologic doses of levothyroxine as adjunctive therapy in bipolar depression: a randomized, double-blind, placebo-controlled study. J Clin Psychiat: 2013; 10.4088/JCP.12m08305 [epub ahead of print]
16. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry: 1960; 23 56 62
17. Montgomery S. A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry: 1979; 134 382 389 (Pubitemid 9136500)
18. Young R. C., Biggs J. T., Ziegler V. E. et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry: 1978; 133 429 435 (Pubitemid 9006756)
19. Uhl I., Gorynia I., Gallinat J. et al. Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects? Hum Psychopharmacol: 2006; 21 463 471 (Pubitemid 44660186)
20. Cuellar A. K., Johnson S. L., Winters R. Distinction between bipolar and unipolar depression. Clin Psychol Rev: 2005; 25 307 339
21. Park Y. M., Lee S. H., Kim S. et al. The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry: 2010; 17 313 316
22. Ostermann J., Uhl I., Köhler E. et al. The loudness dependence of auditory evoked potentials and effects of psychopharmacotherapy and psychopathology in a sample of psychiatric inpatients. Hum Psychopharmacology: 2012; 27 595 604
23. Linka T., Sartory G., Gastpar M. et al. Clinical symptoms of major depression are associated with the intensity dependence of auditory event-related potential components. Psychiatry Res: 2009; 30 139 143 (Pubitemid 40965968)
24. Juckel G., Pogarell O., Augustin H. et al. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J Clin Psychiatry: 2007; 68 1206 1212 (Pubitemid 47395622)
25. Park Y. M., Kim D. W., Kim S. et al. The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder. Psychopharmacology (Berl): 2011; 213 625 632
26. Oliva J., Leung S., Croft R. J. et al. The loudness dependence auditory evoked potential is insensitive to acute changes in serotonergic and noradrenergic neurotransmission. Hum Psychopharmacol: 2010; 25 423 427
27. Simmons J. G., Nathan P. J., Berger G. et al. Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants. Psychopharmacology (Berl): 2011; 217 101 110